Tokyo, Japan

Saki Banjo

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saki Banjo. Retrieved from https://idiyas.com/inventor/saki-banjo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Saki Banjo: Innovator in Pharmaceutical Chemistry

Introduction

Saki Banjo is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Her work focuses on compounds that exhibit specific biological activities, which can lead to advancements in medical treatments.

Latest Patents

Saki Banjo holds a patent for a 3-phenylpropylamine derivative. This invention aims to provide a novel compound with SF-1 antagonist activity and a polyfunctional molecule containing a moiety corresponding to the compound. The patent details a compound represented by a specific formula, which has potential applications in the development of SF-1 degraders.

Career Highlights

Saki Banjo is currently employed at Daiichi Sankyo Company, Limited, where she continues her research and development efforts. Her innovative work has led to the creation of a compound that could have significant implications in the pharmaceutical industry. With her expertise, she contributes to the advancement of drug discovery and development.

Collaborations

Saki collaborates with notable colleagues, including Hideaki Kageji and Tomoharu Tsukada. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Saki Banjo is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new medical advancements. Her patent on the 3-phenylpropylamine derivative exemplifies her commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…